Activation of human T-helper/inducer cell, T-cytotoxic cell, B-cell, and natural killer (NK)-cells and induction of natural killer cell activity against K562 chronic myeloid leukemia cells with modified citrus pectin

BMC Complement Altern Med. 2011 Aug 4;11:59. doi: 10.1186/1472-6882-11-59.

Abstract

Background: Modified citrus pectin (MCP) is known for its anti-cancer effects and its ability to be absorbed and circulated in the human body. In this report we tested the ability of MCP to induce the activation of human blood lymphocyte subsets like T, B and NK-cells.

Methods: MCP treated human blood samples were incubated with specific antibody combinations and analyzed in a flow cytometer using a 3-color protocol. To test functionality of the activated NK-cells, isolated normal lymphocytes were treated with increasing concentrations of MCP. Log-phase PKH26-labeled K562 leukemic cells were added to the lymphocytes and incubated for 4 h. The mixture was stained with FITC-labeled active form of caspase 3 antibody and analyzed by a 2-color flow cytometry protocol. The percentage of K562 cells positive for PKH26 and FITC were calculated as the dead cells induced by NK-cells. Monosaccharide analysis of the MCP was performed by high-performance anion-exchange chromatography with pulse amperometric detection (HPAEC-PAD).

Results: MCP activated T-cytotoxic cells and B-cell in a dose-dependent manner, and induced significant dose-dependent activation of NK-cells. MCP-activated NK-cells demonstrated functionality in inducing cancer cell death. MCP consisted of oligogalacturonic acids with some containing 4,5-unsaturated non-reducing ends.

Conclusions: MCP has immunostimulatory properties in human blood samples, including the activation of functional NK cells against K562 leukemic cells in culture. Unsaturated oligogalacturonic acids appear to be the immunostimulatory carbohydrates in MCP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies
  • Antineoplastic Agents, Phytogenic / analysis
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • B-Lymphocytes / cytology
  • B-Lymphocytes / drug effects
  • Caspase 3 / immunology
  • Cell Death / drug effects
  • Citrus / chemistry*
  • Dose-Response Relationship, Drug
  • Humans
  • K562 Cells
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / drug effects*
  • Leukemia / drug therapy*
  • Leukemia / immunology
  • Leukocytes / cytology
  • Leukocytes / drug effects*
  • Lymphocyte Activation / drug effects*
  • Oligosaccharides / analysis
  • Oligosaccharides / pharmacology
  • Oligosaccharides / therapeutic use
  • Organic Chemicals / metabolism
  • Pectins / chemistry
  • Pectins / pharmacology
  • Pectins / therapeutic use*
  • Phytotherapy*
  • T-Lymphocytes, Cytotoxic / cytology
  • T-Lymphocytes, Cytotoxic / drug effects
  • T-Lymphocytes, Helper-Inducer / drug effects

Substances

  • Antibodies
  • Antineoplastic Agents, Phytogenic
  • Oligosaccharides
  • Organic Chemicals
  • PKH 26
  • oligogalacturonic acid
  • Pectins
  • Caspase 3